Correction: A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1)

erratum OA: gold CC0 ⤵ 4 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

This pilot trial investigated the efficacy of Omega-3 polyunsaturated fatty acids for treating endometriosis-associated pain in women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

This document is a correction to a previously published two-arm, parallel, double-blind randomized controlled pilot trial assessing the efficacy of omega-3 polyunsaturated fatty acids for women with endometriosis-associated pain (PurFECT1). The correction specifically updates the Author Contributions for Ibtisam M. Abokhrais, revising her listed roles to include formal analysis, investigation, project administration, visualization, and writing of the original draft. No changes to the trial design, results, or conclusions are described. This paper is centrally about endometriosis — it corrects authorship information for the PurFECT1 trial focused on endometriosis-associated pain.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0227695.].
Full text 1,284 characters · extracted from oa-doi-fallback · click to expand
There are errors in the Author Contributions for Ibtisam M. Abokhrais. The correct contributions for Ibtisam M. Abokhrais are: Formal analysis, Investigation, Project administration, Visualization, Writing–original draft. Reference - 1. Abokhrais IM, Denison FC, Whitaker LHR, Saunders PTK, Doust A, Williams LJ, et al. (2020) A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1). PLoS ONE 15(1): e0227695. https://doi.org/10.1371/journal.pone.0227695 pmid:31951599 Citation: Abokhrais IM, Denison FC, Whitaker LHR, Saunders PTK, Doust A, Williams LJ, et al. (2020) Correction: A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1). PLoS ONE 15(2): e0230055. https://doi.org/10.1371/journal.pone.0230055 Published: February 27, 2020 Copyright: © 2020 Abokhrais et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (1)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:11.167363+00:00
License: CC0 · commercial use OK